Prolonged response to pemigatinib in metastatic carcinoma ex pleomorphic adenoma with FGFR2–BICC1 fusion: a case report
Year: 2025
Type: preprint
Study design: Case Report
Abstract: Key Clinical MessageThis case highlights the prolonged clinical response to pemigatinib in a patient with metastatic carcinoma ex pleomorphic adenoma harboring an FGFR2-BICC1 fusion, emphasizing the potential role of FGFR inhibition in rare salivary gland malignancies with actionable genomic alterations.
Authors: Diego Iglesias Riera, Carlos Franco, Carlos Lopez Mula, Celia Santamaria
Institution: Hospital Can Misses
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4414206246
Cites:
Cited by:
Related to: